LOS ANGELES, Calif., Jan. 27, 2005 (PRIMEZONE) -- Victor Industries (OTCBB:VICI), is pleased to announce the Company has entered into a joint venture with one of the country's largest pet hospitals to complete development of a diagnostic pet litter to be marketed under the name Pet Well Diagnostic Litter.
Granules incorporated in the litter have been designed to change color if the pet using the litter exhibits symptoms of FUS (Feline Urinary Syndrome), a potentially lethal urinary tract disorder which affects 30% of all cats during their lifetime.
"This will be the first commercially viable, integrated diagnostic cat litter on the market," said Management Consultant Steve Salzburg. "We are working closely with a senior board member and nationally recognized doctor of veterinary medicine on the board of the pet hospital group. The doctor, has been instrumental in the development, commercialization and validation of our Pet Well litter as well as our growing line of all natural veterinary pet preparations."
These products include Pet Well Olive Leaf Compound (U.S. Patent #6,117844) the only all-in-one anti bacterial, anti-viral and anti-parasitic wellness preparation for pets, and Pet Flex an all-natural superior glucosinum/condroitin joint formula.
Participation with this large pet hospital group not only validates our products but could result in orders in excess of 50,000 pounds per week for litter alone.
Other opportunities for Victor's core line of agricultural/horticultural and GSA related products continue to be pursued with vigor and will be the focus of press releases in the near future.
Victor's website has been reconstructed and further information about Victor Industries can found on the web at www.VictorIndustries.com
This news release may contain forward-looking statements within the meaning of Sectin 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended; such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The Company may experience significant fluctuations in operating results due to a number of economic, competitive and other factors. These factors could cause operations to vary significantly from prior periods, and those projected in forward-looking statements. Information with respect to these factors which could materially affect the Company and its operations are included on certain forms the Company files with the Securities and Exchange Commission